U.S. Markets open in 1 hr 27 mins
  • S&P Futures

    4,273.50
    -44.25 (-1.02%)
     
  • Dow Futures

    33,671.00
    -372.00 (-1.09%)
     
  • Nasdaq Futures

    13,861.50
    -125.25 (-0.90%)
     
  • Russell 2000 Futures

    1,897.60
    -30.70 (-1.59%)
     
  • Crude Oil

    87.20
    +0.59 (+0.68%)
     
  • Gold

    1,786.70
    -8.30 (-0.46%)
     
  • Silver

    22.50
    -0.18 (-0.78%)
     
  • EUR/USD

    1.1135
    -0.0012 (-0.1114%)
     
  • 10-Yr Bond

    1.8070
    0.0000 (0.00%)
     
  • Vix

    32.66
    +0.70 (+2.19%)
     
  • GBP/USD

    1.3382
    +0.0001 (+0.0040%)
     
  • USD/JPY

    115.6460
    +0.3440 (+0.2983%)
     
  • BTC-USD

    36,288.29
    -416.03 (-1.13%)
     
  • CMC Crypto 200

    822.33
    +2.82 (+0.34%)
     
  • FTSE 100

    7,425.43
    -128.88 (-1.71%)
     
  • Nikkei 225

    26,717.34
    +547.04 (+2.09%)
     

NNOX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of December 6, 2021 in the Class Action Filed on Behalf of Nano-X Imaging Ltd. Limited Shareholders

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • NNOX

New York, New York--(Newsfile Corp. - November 30, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Nano-X Imaging Ltd. (NASDAQ: NNOX) alleging that the Company violated federal securities laws.

Class Period: June 17, 2021 to August 18, 2021
Lead Plaintiff Deadline: December 6, 2021
No obligation or cost to you.

Learn more about your recoverable losses in NNOX:
https://www.kleinstocklaw.com/pslra-1/nano-x-imaging-ltd-loss-submission-form-2?id=21782&from=5

Nano-X Imaging Ltd. NEWS - NNOX NEWS

CLASS ACTION CASE DETAILS: The filed complaint alleges that Nano-X Imaging Ltd. made materially false and/or misleading statements and/or failed to disclose that: (i) Nano-X's 510(k) application for the Nanox.ARC was deficient; (ii) accordingly, it was unlikely that the Food and Drug Administration would approve the 510(k) application for the Nanox.ARC in its current form; (iii) as a result, NanoX had overstated the Nanox.ARC's regulatory and commercial prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in Nano-X you have until December 6, 2021 to petition the court for lead plaintiff status. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you purchased Nano-X securities during the relevant period, you may be entitled to compensation without payment of any out-of-pocket fees.

HOW TO PROTECT YOUR FINANCIAL INTERESTS: For additional information about the NNOX lawsuit, please contact J. Klein, Esq. by telephone at 212-616-4899 or click this link.

ABOUT KLEIN LAW FIRM
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. The Klein Law Firm is a boutique litigation firm with experience in a wide range of areas including securities law, corporate finance and commercial litigation. Since 2011, our experienced attorneys have achieved superior results for our clients with a personalized focus. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/106019